Cytokinetics, Inc. (NASDAQ: CYTK) has received a price target increase from Citigroup, which raised its target from $77.00 to $84.00, as detailed in a research report...
Shares of Molson Coors Beverage Company (NYSE:TAP) have garnered a consensus recommendation of “Hold” from a network of sixteen research firms, according to data from MarketBeat...